ATE237639T1 - Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper - Google Patents

Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper

Info

Publication number
ATE237639T1
ATE237639T1 AT98922500T AT98922500T ATE237639T1 AT E237639 T1 ATE237639 T1 AT E237639T1 AT 98922500 T AT98922500 T AT 98922500T AT 98922500 T AT98922500 T AT 98922500T AT E237639 T1 ATE237639 T1 AT E237639T1
Authority
AT
Austria
Prior art keywords
oocyst
igg1
animal
oocysts
cryptosporidium
Prior art date
Application number
AT98922500T
Other languages
English (en)
Inventor
Graham Vesey
Christopher Weir
Keith Leslie Williams
Martin Basil Slade
Duncan Veal
Original Assignee
Macquarie Res Ltd
Australian Water Technologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO6962A external-priority patent/AUPO696297A0/en
Priority claimed from AUPO8242A external-priority patent/AUPO824297A0/en
Application filed by Macquarie Res Ltd, Australian Water Technologies filed Critical Macquarie Res Ltd
Application granted granted Critical
Publication of ATE237639T1 publication Critical patent/ATE237639T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
AT98922500T 1997-05-19 1998-05-19 Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper ATE237639T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO6962A AUPO696297A0 (en) 1997-05-19 1997-05-19 Antibodies to cryptosporidium
AUPO8242A AUPO824297A0 (en) 1997-07-25 1997-07-25 Antibodies to cryptosporidium
PCT/AU1998/000368 WO1998052974A1 (en) 1997-05-19 1998-05-19 ANTIBODIES TO $i(CRYPTOSPORIDIUM)

Publications (1)

Publication Number Publication Date
ATE237639T1 true ATE237639T1 (de) 2003-05-15

Family

ID=25645429

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98922500T ATE237639T1 (de) 1997-05-19 1998-05-19 Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper

Country Status (6)

Country Link
US (1) US6777222B1 (de)
EP (1) EP0991667B1 (de)
AT (1) ATE237639T1 (de)
DE (1) DE69813555T2 (de)
ES (1) ES2201490T3 (de)
WO (1) WO1998052974A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475747B2 (en) * 1997-10-28 2002-11-05 The United States Of America As Represented By The Department Of Health And Human Services Method for detecting Cryptosporidium parvum oocysts
US20070141710A1 (en) * 2005-12-20 2007-06-21 Beckman Coulter, Inc. Stable calibrators for immunoassays
US10429386B2 (en) 2015-03-10 2019-10-01 The Regents Of The University Of California Antibodies to the surface of Toxoplasma gondii oocysts and methods of use thereof
CN116143875A (zh) * 2022-07-09 2023-05-23 吉林大学 隐孢子虫cgd2_3080卵囊壁外壁标记蛋白质及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN514695A0 (en) * 1995-08-30 1995-09-21 Australian Water Technologies Pty Ltd Method for detection of cryptosporidium oocysts

Also Published As

Publication number Publication date
EP0991667A1 (de) 2000-04-12
ES2201490T3 (es) 2004-03-16
EP0991667A4 (de) 2000-12-20
DE69813555D1 (de) 2003-05-22
DE69813555T2 (de) 2004-04-29
EP0991667B1 (de) 2003-04-16
WO1998052974A1 (en) 1998-11-26
US6777222B1 (en) 2004-08-17

Similar Documents

Publication Publication Date Title
ZA837603B (en) Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine
BG100641A (en) In ovo vaccination against coccidiosis
EP2363484A3 (de) Humanisierter Antikörper gegen den menschlichen Gewebefaktor (TF) und Verfahren zur Herstellung des humanisierten Antikörpers
SI0970126T1 (en) Novel method for the production of antihuman antigen receptors and uses thereof
ES2002467A6 (es) Procedimiento para la preparacion de un antigeno peptido inmunogenico correspondiente a la proteina circumsporozoito de plasmodium vivax
EP1964573A3 (de) Verfahren zur Induzierung und/oder Verbesserung einer Immunreaktion auf Tumorantigene
BR9809656A (pt) Composição imunopotencializante
EP0135712A3 (de) Gegen Sporozoiten von Eimeria Spp. reaktive monoklonale Antikörper und Antigene
DE2967036D1 (en) Vaccine and method of making
EP2058334A3 (de) Monoklonale Antikörper, querschnittsreaktive Antikörper und Verfahren zu ihrer Herstellung
WO1995026982A3 (en) Malaria peptides
ATE237639T1 (de) Gegen die fläche von cryptosporidium-oozysten gerichteten igg1-klasse antikörper
EP0348725A3 (de) Sorten-spezifische Epitode von Chlamydia trachomatis und Antikörper, die diese erkennen
NZ216119A (en) Vaccine produced using antigens of a pseudocapsule producing strain of s.aureus
DE69031426T2 (de) Impfstoff zur immunisierung von katzen gegen toxoplasmen ohne verbreitung der oozysten
JPS6445398A (en) Antithrombin-binding substance monoclonal antibody, hybridoma producing said antibody and method for purifying and measuring thrombin-binding substance utilizing said monoclonal antibody
IL93234A (en) Methods for producing antibodies, antibody probes produced thereby, method for preparing and using antigens utilizing said probes and vaccines prepared therewith
EP0241139A3 (de) Antiidiotypischer Coccidiaimpfstoff
HK1048323A1 (en) Production of mammary secretion antibodies in farmanimals
DE3671603D1 (de) Verfahren zur zucht von babesia canis, verwendung zur herstellung von antigenen und impfstoffen und antigene und impfstoffe gegen piroplasmose.
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
DE244295T1 (de) Aus weichtieren isoliertes immunogen, verfahren zur herstellung desselben, diagnostische reagenzien fuer menschliche bilharziosen, impfstoffe gegen schistosomiasis und immunisierende zubereitungen, die dieses immunogen enthalten.
JPS6429400A (en) Monoclonal antibody
DK0476059T3 (da) Fremgangsmåder til forøgelse af modificeringshastigheden for metastabile bindinger
IT1254147B (it) Metodo di rivelazione di marcatori tumorali.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties